US 11,745,015 B2
Neurostimulator with titration assist
Scott Stubbs, Maple Grove, MN (US); Imad Libbus, St. Paul, MN (US); Scott Mazar, Woodbury, MN (US); Bruce H. KenKnight, Maple Grove, MN (US); and Badri Amurthur, Los Gatos, CA (US)
Assigned to LivaNova USA, Inc., Houston, TX (US)
Filed by LivaNova USA, Inc., Houston, TX (US)
Filed on Oct. 15, 2021, as Appl. No. 17/503,094.
Application 17/503,094 is a continuation of application No. 16/185,838, filed on Nov. 9, 2018, granted, now 11,147,972.
Application 16/185,838 is a continuation of application No. 15/181,177, filed on Jun. 13, 2016, granted, now 10,124,170.
Prior Publication US 2022/0105347 A1, Apr. 7, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61N 1/36 (2006.01)
CPC A61N 1/36114 (2013.01) [A61N 1/36053 (2013.01); A61N 1/36139 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A method of titrating a neurostimulation signal delivered to a patient from an implantable pulse generator, the method comprising:
setting a titration hold point prior to titrating the neurostimulation signal, the titration hold point corresponding to a holding set of stimulation parameters;
titrating the neurostimulation signal from a first set of parameters toward a target set of parameters;
receiving a hold indicator, the hold indicator indicating that the neurostimulation signal is being delivered at the holding set of stimulation parameters;
initiating an intermediate hold of the titrating of the neurostimulation signal in response to receiving the hold indicator, the intermediate hold being a continuation of the neurostimulation signal being delivered at the holding set of stimulation parameters; and
receiving an indication of a titration resumption that discontinues the intermediate hold.